Overview

Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy

Status:
Completed

Trial end date:
2009-05-01

Target enrollment:

Participant gender:

Summary

A multicenter study to evaluate lung function and symptoms in subjects with COPD who have been on regular use of only one long-acting bronchodilator.

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Bronchodilator Agents